CEO
Samarth Kulkarni is the Chief Executive Officer and Director of CRISPR Therapeutics AG (CRSP), a position he has held since December 2017, and he also serves as Chairman of the company's board since September 2023.[[1]](https://www.marketscreener.com/insider/SAMARTH-KULKARNI-A1XM0H/)[[3]](https://clay.earth/profile/samarth-kulkarni)[[4]](https://fintool.com/app/research/companies/BDTX/people/samarth-kulkarni) He joined CRISPR Therapeutics in 2015 as Chief Business Officer, where he played a key role in establishing strategic partnerships with Bayer and Vertex, supporting financing efforts, and leading the company's initial public offering (IPO).[[3]](https://clay.earth/profile/samarth-kulkarni)[[5]](https://vaticanconference2018.com/samarth-sam-kulkarni-phd/) Dr. Kulkarni is also Chairman of Casebia Therapeutics LLP, a joint venture between CRISPR Therapeutics and Bayer, and serves on the boards of Black Diamond Therapeutics, Inc., Repare Therapeutics, Inc., Centessa Pharmaceuticals Ltd., and Oruka Therapeutics, Inc.[[1]](https://www.marketscreener.com/insider/SAMARTH-KULKARNI-A1XM0H/)[[3]](https://clay.earth/profile/samarth-kulkarni)[[4]](https://fintool.com/app/research/companies/BDTX/people/samarth-kulkarni) Additionally, he is Director of the Emerging Companies Section at the Biotechnology Innovation Organization.[[1]](https://www.marketscreener.com/insider/SAMARTH-KULKARNI-A1XM0H/)
Prior to CRISPR, Samarth Kulkarni was a Partner at McKinsey & Company from 2006 to July 2015, co-leading the biotech practice and advising on strategy, operations, personalized medicine, and immunotherapy, with several co-authored publications.[[1]](https://www.marketscreener.com/insider/SAMARTH-KULKARNI-A1XM0H/)[[2]](https://allaboutbelgaum.com/news/samarth-kulkarni-belagavi-now-ceo-crispr-therapeutics/)[[5]](https://vaticanconference2018.com/samarth-sam-kulkarni-phd/) He earned a Ph.D. in bioengineering and nanotechnology from the University of Washington, where he researched biological drug delivery and molecular diagnostics, and a B.Tech. in biotechnology and biochemical engineering from the Indian Institute of Technology Kharagpur.[[1]](https://www.marketscreener.com/insider/SAMARTH-KULKARNI-A1XM0H/)[[2]](https://allaboutbelgaum.com/news/samarth-kulkarni-belagavi-now-ceo-crispr-therapeutics/)[[3]](https://clay.earth/profile/samarth-kulkarni)[[5]](https://vaticanconference2018.com/samarth-sam-kulkarni-phd/) Originally from Belagavi, India, he attended Rashtriya Military School and excelled academically early in his career.[[2]](https://allaboutbelgaum.com/news/samarth-kulkarni-belagavi-now-ceo-crispr-therapeutics/)
View full insider profile →
